---
figid: PMC4807161__ijbsv12p0409g003
figtitle: Physiological and anatomical targets of FDA-approved drugs for prostate
  cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
organisms_ner:
- NA
pmcid: PMC4807161
filename: ijbsv12p0409g003.jpg
figlink: /pmc/articles/PMC4807161/figure/F3/
number: F3
caption: 'Physiological and anatomical targets of FDA-approved drugs for prostate
  cancer. LHRH produced by the hypothalamus stimulates production of LH by the anterior
  pituitary. LH then activates the production of testosterone by the testes. Gonadal
  testosterone, along with testosterone produced by the adrenal glands and the prostate
  itself, activates transcription of ARGs. Currently approved therapies for advanced
  PCa target multiple nodes along this physiological pathway. LHRH: Luteinizing hormone
  releasing hormone; LH: Luteinizing hormone; CYP17: Cytochrome P450-C17; T: Testosterone;
  DHT: Dihydrotestosterone; DHEA: Dehydroepiandrosterone; AR: androgen receptor; ARE:
  Androgen response element.'
papertitle: Therapeutic Rationales, Progresses, Failures, and Future Directions for
  Advanced Prostate Cancer.
reftext: Kristine M Wadosky, et al. Int J Biol Sci. 2016;12(4):409-426.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.842408
figid_alias: PMC4807161__F3
figtype: Figure
redirect_from: /figures/PMC4807161__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4807161__ijbsv12p0409g003.html
  '@type': Dataset
  description: 'Physiological and anatomical targets of FDA-approved drugs for prostate
    cancer. LHRH produced by the hypothalamus stimulates production of LH by the anterior
    pituitary. LH then activates the production of testosterone by the testes. Gonadal
    testosterone, along with testosterone produced by the adrenal glands and the prostate
    itself, activates transcription of ARGs. Currently approved therapies for advanced
    PCa target multiple nodes along this physiological pathway. LHRH: Luteinizing
    hormone releasing hormone; LH: Luteinizing hormone; CYP17: Cytochrome P450-C17;
    T: Testosterone; DHT: Dihydrotestosterone; DHEA: Dehydroepiandrosterone; AR: androgen
    receptor; ARE: Androgen response element.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Nilutamide
  - Bicalutamide
  - Abiraterone
  - Enzalutamide
  - Cholesterol
  - DHEA
  - Flutamide
  - Ketoconazole
  - Leuprolide
  - Triptorelin
  - Finasteride
---
